Paul Sugarbaker

Paul Hendrick Sugarbaker (born November 28, 1941 in Baltimore) is an American surgeon at the Washington Cancer Institute. He is known for developments in surgical oncology of the abdomen, including cytoreductive surgery followed by cytohyperthermic intraperitoneal chemotherapy,[1] or HIPEC, a controversial treatment alternately referred to as the Sugarbaker Process and the Hot Chemotherapy Bath.[2][3]

Sugarbaker attended high school in Jefferson City, Missouri and received a Bachelor's Degree from Wheaton College in Illinois in 1963. In 1967 he graduated from the medical college at Cornell University. He interned and did his residency at Peter Bent Brigham Hospital in Boston, serving as chief resident from 1973 to 1976. He then spent ten years as a Senior Surgeon at the National Cancer Institute of the National Institutes of Health in Bethesda, Maryland, most recently as Head of Colon Cancer Surgery. He was also head of surgical oncology at Emory University Medical School, and the medical director director of surgical oncology at the Washington Cancer Institute at the MedStar Washington Hospital Center.[3]

References

  1. ↑ Neuwirth, Madalyn G.; Alexander, H. Richard; Karakousis, Giorgos C. (February 1, 2016). "Then and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspective". Journal of Gastrointestinal Oncology. 7 (1): 18–28. ISSN 2078-6891. PMC 4754315. PMID 26941981.
  2. ↑ Pollack, Andrew (2011-08-11). "Heated, Harrowing Chemotherapy Bath May Be Only Hope for Some". The New York Times. ISSN 0362-4331. Retrieved 2018-04-22.
  3. 1 2 Wilber, Del Quentin (2012-11-25). "Surgeon performs controversial cancer surgery named after him". Washington Post. ISSN 0190-8286. Retrieved 2018-04-22.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.